Follow
Punit Seth
Punit Seth
Alnylam Pharmaceuticals
Verified email at alnylam.com
Title
Cited by
Cited by
Year
6-modified bicyclic nucleic acid analogs
EES Punit P. Seth
US Patent 7,741,457, 2010
591*2010
6-modified bicyclic nucleic acid analogs
PP Seth, EE Swayze
US Patent 7,399,845, 2008
5912008
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
TP Prakash, MJ Graham, J Yu, R Carty, A Low, A Chappell, K Schmidt, ...
Nucleic acids research 42 (13), 8796-8807, 2014
5662014
5′-modified bicyclic nucleic acid analogs
PP Seth, EE Swayze, B Bhat
US Patent 7,547,684, 2009
4282009
The medicinal chemistry of therapeutic oligonucleotides
WB Wan, PP Seth
Journal of medicinal chemistry 59 (21), 9645-9667, 2016
3772016
Compounds and methods for synthesis of bicyclic nucleic acid analogs
B Bhat, J Xia, PP Seth, G Vasquez, MT Migawa, C Allerson, TP Prakash, ...
US Patent 7,569,686, 2009
2752009
Short antisense oligonucleotides with novel 2′− 4′ conformationaly restricted nucleoside analogues show improved potency without increased toxicity in animals
PP Seth, A Siwkowski, CR Allerson, G Vasquez, S Lee, TP Prakash, ...
Journal of medicinal chemistry 52 (1), 10-13, 2009
2742009
Single-stranded siRNAs activate RNAi in animals
WF Lima, TP Prakash, HM Murray, GA Kinberger, W Li, AE Chappell, ...
Cell 150 (5), 883-894, 2012
2722012
Synthesis and Biophysical Evaluation of 2′,4′-Constrained 2′O-Methoxyethyl and 2′,4′-Constrained 2′O-Ethyl Nucleic Acid Analogues
PP Seth, G Vasquez, CA Allerson, A Berdeja, H Gaus, GA Kinberger, ...
The Journal of organic chemistry 75 (5), 1569-1581, 2010
2432010
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
W Shen, CL De Hoyos, MT Migawa, TA Vickers, H Sun, A Low, TA Bell III, ...
Nature biotechnology 37 (6), 640-650, 2019
2392019
Bis-modified bicyclic nucleic acid analogs
PP Seth, EE Swayze
US Patent 7,666,854, 2010
2222010
SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain
PP Seth, A Miyaji, EA Jefferson, KA Sannes-Lowery, SA Osgood, ...
Journal of medicinal chemistry 48 (23), 7099-7102, 2005
1912005
Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS
ME Østergaard, AL Southwell, H Kordasiewicz, AT Watt, NH Skotte, ...
Nucleic acids research 41 (21), 9634-9650, 2013
1742013
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts
SA Burel, CE Hart, P Cauntay, J Hsiao, T Machemer, M Katz, A Watt, ...
Nucleic acids research 44 (5), 2093-2109, 2016
1712016
Targeted delivery of antisense oligonucleotides to pancreatic β-cells
C Ämmälä, WJ Drury III, L Knerr, I Ahlstedt, P Stillemark-Billton, ...
Science advances 4 (10), eaat3386, 2018
1562018
Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages
WB Wan, MT Migawa, G Vasquez, HM Murray, JG Nichols, H Gaus, ...
Nucleic acids research 42 (22), 13456-13468, 2014
1552014
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver
CM Miller, AJ Donner, EE Blank, AW Egger, BM Kellar, ME Østergaard, ...
Nucleic acids research 44 (6), 2782-2794, 2016
1542016
Carbocyclic alpha-L-bicyclic nucleic acid analogs
PP Seth, EE Swayze
US Patent 8,546,556, 2013
1542013
Substituted alpha-L-bicyclic nucleosides
PP Seth, EE Swayze
US Patent 8,501,805, 2013
1542013
In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides
AL Southwell, NH Skotte, HB Kordasiewicz, ME Østergaard, AT Watt, ...
Molecular Therapy 22 (12), 2093-2106, 2014
1502014
The system can't perform the operation now. Try again later.
Articles 1–20